DCL: Explanation for consolidated business result in QII/2013

Cuu Long Pharmaceutical Joint Stock Corporation (PHARIMEXCO) explained the fluctuation in consolidated profit in Quarter II/2013 compared to Quarter II/2012 as follows:

-         Consolidated profit after tax in Quarter II/2013: VND14,218,906,025

-         Consolidated profit after tax in Quarter II/2012: -VND1,707,147,061

-         The consolidated profit after tax in Quarter I/2013 increased by VND15,926,053,086 (equivalent to over 10%) compared to the consolidated profit after tax in Quarter II/2012 because:

+         Financial expense in Quarter II/2013 was VND7.8 billion, decreasing VND9.3 billion compare to Quarter II/2012 because interest rate decreased. 

HOSE

>   OPC: Explanation for business results for 6 months of 2013 before & after review (20/08/2013)

>   STB: Explanation for business result in Quarter 2.2013 (20/08/2013)

>   SGC: Reviewed financial statement 2013 (20/08/2013)

>   SEL: Reviewed financial statement 2013 (20/08/2013)

>   L35: Reviewed financial statement 2013 (20/08/2013)

>   VC9: Financial Statement Quarter 2/2013 (consolidated) (20/08/2013)

>   PSI: Reviewed financial statement 2013 (20/08/2013)

>   BVS: Reviewed financial statement 2013 (20/08/2013)

>   VC9: Financial Statement Quarter 2/2013 (holding company) (20/08/2013)

>   BKC: Reviewed financial statement 2013 (holding company) (20/08/2013)